CAS: 485-72-3; 7-Hydroxy-3-(4-Methoxyphenyl)-4H-Chromen-4-One

该化合物是一种天然的草质,主要存在于各种植物中,特别是诸如红三叶素和大豆等豆类中,主要存在于各种植物中.认识到它与雌激素在结构上具有相似性,因此它能够表现出雌激素活动,从而有可能影响体内的激素平衡.在安全方面,它一般被视为中度饮食量安全,但为了充分理解其药理学影响和与药物的潜在相互作用,必须进行进一步的研究.总的来说,福松尼是营养科学和药理学方面的一个重要研究领域,因为其生物活动多种多样.

结构式图片

相似化合物

21913-98-4 491-80-5 552-59-0

欧盟法规

REACH注册ECHA物质C&L通报REACH预注册

上下游产品

CAS号2632-13-5 4-甲氧基-α-溴代苯乙酮 | CAS号95-01-2 2,4-二羟基苯甲醛 | CAS号487-49-0 Ononetin | CAS号68-12-2 N,N-二甲基甲酰胺 | CAS号486-66-8 大豆苷元 | CAS号10499-17-9 3-(4-methoxyphe... | CAS号486-62-4 芒柄花苷 | CAS号897-46-1 6,7-二羟基-4-甲氧基异黄酮 | CAS号37816-19-6 7,8-Dihydroxy-4... | CAS号20575-57-9 毛蕊异黄酮 | CAS号486-66-8 大豆苷元 | CAS号531-95-3 雌马酚 | CAS号1157-39-7 大豆苷元甲醚 | CAS号32383-76-9 美迪紫檀素 | CAS号949021-68-5 芒柄花黄素-3'-磺酸钠

合成工艺路线路线简述

  • 合成目标产物 Formononetin 主要起始原料 2-Bromo-4'-Methoxyacetophenone And 2,4-Dihydroxybenzaldehyde
  • (文献来源)合成步骤主要原料 2-Bromo-4'-Methoxyacetophenone 和 2,4-Dihydroxybenzaldehyde
芒柄花苷置于盐酸体系中,化学反应生成 刺芒柄花素
参考文献:Isoflavonoids In The Roots Of Thermopsis Fabacea D.C. (Leguminosae).
标题:Isoflavonoids In The Roots Of Thermopsis Fabacea D.C. (Leguminosae).
摘要:从thermopsis Fabacea D.C.(豆科植物)的根中分离出九种异黄酮(i-Ix).c. (豆科植物)中分离出了九种异黄酮类化合物(i-Ix).甲醇提取物可得到甲萘素(i)和大豆异黄酮(II),乙醚提取物可得到三叶异黄酮(iii),Dl-Maackiain(iv),染料木素(v)和 7,3'-二羟基-4'-甲氧基异黄酮(vi),乙酸乙酯提取物可得到甲萘素-7-O-β-D-葡萄糖苷(vii),大豆异黄酮(viii)和染料木素(ix).通过降解,光谱研究以及与真品直接比较,对这些化合物进行了鉴定.
DOI:10.1248/cpb.28.3686

海关参考信息

专利信息


专利号:US-2012003164-A1
优先权日:1998-12-30
标题 :Cosmetic or dermatological composition containing an active agent which stimulates synthesis of the protein hsp 32 in the skin
发明人:NIZARD CARINE; MOREAU MARIELLE; BONTE FREDERIC
权利人:NIZARD CARINE; MOREAU MARIELLE; BONTE FREDERIC; DIOR CHRISTIAN PARFUMS
摘要:A dermatological or cosmetological composition for an external topical administration, included together with pharmaceutically and/or cosmetologically acceptable excipients: at least one UVA-stabilizing and/or UVB-stabilizing screening agent, at least one compound capable of activating the endogenous synthesis of Heat Shock Protein (HSP) 32 or a functional peptide fragment of such a protein, and forskolin or any extract containing it.

专利号:EP-1140000-B1
优先权日:1998-12-30
标 题 :Cosmetic or dermatological composition containing an active principle stimulating hsp 32 protein synthesis in the skin and cosmetic treatment method
发明人:NIZARD CARINE; MOREAU MARIELLE; BONTE FREDERIC
权利人:DIOR CHRISTIAN PARFUMS
摘要:The invention concerns a dermatological or cosmetological composition, characterised in that it contains at least a compound capable of activating HSP 32 endogenetic synthesis or a functional peptide fragment of such a protein with pharmaceutically and/or cosmetologically acceptable carriers. The invention also concerns the use of a compound selected from the group consisting of procyanidolic oligomers (PCO) and their derivatives, caffeic acid esters and their derivatives and mixtures of said compounds, for preparing a composition designed to activate endogenetic synthesis of HSP 32 or a functional peptide fragment of such a protein.

专利号:US-2009062555-A1
优先权日:2007-08-28
标 题 :Synthesis of Isoflavone
发明人:HARMS ARTHUR E
权利人:HARMS ARTHUR E
摘要:The invention provides a process of manufacturing an isoflavone of the general formula 7 n n n n n n n n n n wherein R 1 , R 2 , R 3 , and R 4 each independently are H, OH, or an alkoxy, provided at least one of R 1 , R 2 , R 3 , and R 4 being OH, and one being alkoxy, or at least 2 groups being OH, comprising providing ketone (3) n n n n n n n n n n wherein R 1 , R 2 , R 3 , and R 4 are as stated above, combining (3) with trialkylortho formate, and a Lewis or Bronsted acid to produce the isoflavone, precipitating the isoflavone.

专利号:US-8263755-B2
优先权日:2006-11-20
标题:Synthesis of compounds useful as modulators of amyloid-beta production
发明人:FINDEIS MARK A
权利人:FINDEIS MARK A; SATORI PHARMACEUTICALS INC
摘要:As described herein, the present invention provides methods for preparing compounds useful for treating or lessening the severity of a neurodegenerative disorder. The present invention also provides methods of treating or lessening the severity of such disorders wherein said method comprises administering to a patient a compound of the present invention, or composition thereof. Said method is useful for treating or lessening the severity of, for example, Alzheimer's disease.

专利号:US-2014357576-A1
优先权日:2013-05-31
标题:Methods for enhancement of muscle protein synthesis
发明人:BREUILLE DENIS; STELLINGWERFF TRENT; MOORE DANIEL RYAN; OFFORD CAVIN ELIZABETH ANN; PHILLIPS STUART MARTIN
权利人:NESTEC SA
摘要:The present disclosure provides methods for enhancing muscle protein synthesis in an individual in need of same. Specifically, the present disclosure provides methods for enhancing muscle protein synthesis by enhancing myofibrillar muscle protein synthesis. The method includes administering to the individual a mixed macronutrient composition having (i) an amount of whey protein that is not capable of enhancing myofibrillar protein synthesis when ingested by itself and (ii) free leucine. The composition comprises at least about 5.0 g total leucine per dose.

专利号:WO-2015040533-A1
优先权日:2013-09-19
标题:Methods for enhancing muscle protein synthesis during energy deficit
发明人:BAILEY DAVID MARK; ZALTAS ERIC SCOTT; STELLINGWERFF TRENT; MOORE DANIEL RYAN; HAWLEY JOHN ALAN; BURKE LOUISE MARY
权利人:PREMIER NUTRITION CORP
摘要:The present disclosure provides methods for enhancing muscle protein synthesis in an individual in need of same. Specifically, the present disclosure provides methods for enhancing muscle protein synthesis during periods of negative energy balance, or energy deficit. The methods include administering to an individual suffering from energy deficit a composition comprising protein in an amount from about 15 g to about 30 g during a time period selected from the group consisting of during exercise, post-exercise, and combinations thereof. The methods also include administering to an individual suffering from energy deficit a composition comprising protein during a time period selected from the group consisting of during exercise, post-exercise, and combinations thereof, wherein the protein is administered in a dose that is higher than doses typically recommended for individuals experiencing energy balance.
陕西慧科植物开发有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.huikes.com
电话: 0086-4000-999-369👤
📞陕西慧科植物开发有限公司 ⚠️参考联系方式

销售电话:0086-4000-999-369
邮箱:marketing@huikes.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
成都科程生物科技开发有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.cogon-chem.com
电话: 028-85171192👤
📞成都科程生物科技开发有限公司 ⚠️参考联系方式

销售电话:028-85171192
邮箱:cogon_chem@hotmail.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
上海金赛医药化工有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.sjpharm.com
企业联系电话:021-57362983,13301713911👤
📞上海金赛医药化工有限公司 ⚠️参考联系方式

电话:021-57362983,13301713911

传真:021-57362993
邮箱:sales@sjpharm.com
通信地址: 上海市金山区亭枫公路7966号
邮编: 200050
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:上海市金山区亭枫公路7966号
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
台州市博纳化工有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.tzbnchem.com
企业联系电话:0576-88663272👤
📞台州市博纳化工有限公司 ⚠️参考联系方式
联系人:陈
电话:0576-88663272

传真:0576-88707069
邮箱:sales@tzbnchem.com
通信地址: 浙江省台州市椒江区外沙工业园区
邮编: 318000
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:浙江省台州市椒江区外沙工业园区
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献


1: Li S, Dang Y, Zhou X, Huang B, Huang X, Zhang Z, Kwan YW, Chan SW, Leung GP, Lee SM, Hoi MP. Formononetin promotes angiogenesis through the estrogen receptor alpha-enhanced ROCK pathway. Sci Rep. 2015 Nov 16;5:16815. doi: 10.1038/srep16815.
2: Wu XY, Xu H, Wu ZF, Chen C, Liu JY, Wu GN, Yao XQ, Liu FK, Li G, Shen L. Formononetin, a novel FGFR2 inhibitor, potently inhibits angiogenesis and tumor growth in preclinical models. Oncotarget. 2015 Dec 29;6(42):44563-78. doi: 10.18632/oncotarget.6310.
3: Wang H, Zhang D, Ge M, Li Z, Jiang J, Li Y. Formononetin inhibits enterovirus 71 replication by regulating COX- 2/PGE₂ expression. Virol J. 2015 Mar 1;12:35. doi: 10.1186/s12985-015-0264-x.

合成参考文献


参考文献:10.1021/np50001a002
摘要:Edwards JM, Raffauf RF, Le Quesne PW. Antineoplastic activity and cytotoxicity of flavones, isoflavones, and flavanones. J Nat Prod. 1979 Jan;42(1):85–91. doi: 10.1021/np50001a002.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知